The software was not routing information about certain high-risk electrocardiogram events to cardiology technicians as intended. The issue, which lasted from July 2022 to July 2024, included failure to route information about suspected cases of atrial fibrillation or pause, supraventricular tachycardia, ventricular tachycardia and second- or third-degree atrioventricular block.
On Dec. 18, Philips and its subsidiary, Braemar Manufacturing, sent all affected customers an urgent medical device correction and information about which patients may need their data reprocessed.
This is a Class I recall, the FDA’s most serious classification, but does not involve removing devices from where they are used or sold.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
